Press Releases Quest Diagnostics Incorporated

Equities

DGX

US74834L1008

Market Closed - Nyse Other stock markets 04:00:02 2024-04-26 pm EDT			5-day change	1st Jan Change
134.3 ^USD	-0.86%		+4.53%	-2.63%

Apr. 25	Labcorp beats quarterly estimates on strong testing demand	RE
Apr. 24	Jefferies Adjusts Price Target on Quest Diagnostics to $160 From $155	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Quest Diagnostics Foundation and Green Bronx Machine Expand Collaboration To Bring Acclaimed Indoor Gardening Curriculum to More Communities and Raise Awareness for Impact of Nutrition Education on Health Equity	Apr. 26	AQ
Fitch Affirms Quest Diagnostics at 'BBB'; Outlook Remains Positive	Apr. 26	AQ
Quest Diagnostics Reports First Quarter 2024 Financial Results, Raises Guidance for Full Year 2024	Apr. 24	AQ
Quest Diagnostics Incorporated : First Quarter 2024 View Transcript of Company Prepared Comments	Apr. 23	PU
Quest Diagnostics: Q1 Earnings Snapshot	Apr. 23	AQ
Quest Diagnostics Reports First Quarter 2024 Financial Results; Raises Guidance for Full Year 2024	Apr. 23	PR
Quest Diagnostics Adds p-tau217 Blood Biomarker Testing to Suite of Services Designed to Assess Risk and Help Aid Diagnosis of Alzheimer's Disease	Apr. 22	PR
Quest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental Delay	Apr. 03	AQ
Quest Diagnostics - Study in Frontiers in Neurology Affirms Amyloid Blood Test Can Help Identify Patients Who May Forgo Imaging Evaluation for Alzheimer's disease	Mar. 27	AQ
Study in Frontiers in Neurology Affirms Amyloid Blood Test Can Help Identify Patients Who May Forgo Imaging Evaluation for Alzheimer's Disease	Mar. 26	PR
Quest Diagnostics to Release First Quarter 2024 Financial Results on April 23, 2024	Mar. 19	PR
First PFAS "Forever Chemicals" Consumer-Initiated Blood Test With Physician Consult Launches on questhealth.com	Mar. 05	AQ
Ten Years Running: FORTUNE Names Quest Diagnostics One of 2024 "World's Most Admired Companies"	Feb. 28	AQ
Quest Diagnostics to Speak at the Barclays 26th Annual Global Healthcare Conference	Feb. 23	PR
First PFAS "Forever Chemicals" Consumer-Initiated Blood Test with Physician Consult Launches on questhealth.com	Feb. 12	PR
Quest Diagnostics: Q4 Earnings Snapshot	Feb. 01	AQ
Quest Diagnostics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Guidance for Full Year 2024; Increases Quarterly Dividend 5.6% to $0.75 Per Share	Feb. 01	PR
Ten Years Running: FORTUNE Names Quest Diagnostics one of 2024 "World's Most Admired Companies"	Jan. 31	PR
Fitbit and Quest Diagnostics Collaborate To Advance Research on the Use of Wearable Devices To Improve Metabolic Health	Jan. 29	AQ
Quest Diagnostics - Haystack Oncology, developer of Haystack MRD, and TriSalus Life Sciences collaborate in connection with the clinical development of TriSalus TLR9 agonist in hepatocellular carcinoma	Jan. 23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Quest Diagnostics Incorporated

Equities

DGX

US74834L1008

Press Releases

Filters